Heather L McArthur (Heather McArthur)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Locally Advanced

Metastatic Breast Cancer

Tyrosine Kinase

Epidermal Growth Factor Receptor

Top Venues

NPJ breast cancer

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Molecular genetics & genomic medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Alice Y Ho, Stephen Shiao, Samantha A Kobald, Jonathan Chen, Dan G Duda, Amy Ly, Veerle Bossuyt, Hae Lin Cho, Brittany Arnold, Simon Knott, Gaorav P Gupta, Philomena McAndrew, Scott Karlan, Mourad Tighiouart, Alona Muzikansky, Reva K Basho, Heather L McArthur
PEARL: A Phase Ib/II Biomarker Study of Adding Radiation Therapy to Pembrolizumab Before Neoadjuvant Chemotherapy in Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
David B Page, Joanna Pucilowska, Brie Chun, Isaac Kim, Katherine Sanchez, Nicole Moxon, Staci Mellinger, Yaping Wu, Yoshinobu Koguchi, Valerie Conrad, William L Redmond, Maritza Martel, Zhaoyu Sun, Mary B Campbell, Alison Conlin, Anupama Acheson, Reva Basho, Philomena McAndrew, Mary El-Masry, Dorothy Park, Laura Bennetts, Robert S Seitz, Tyler J Nielsen, Kimberly McGregor, Venkatesh Rajamanickam, Brady Bernard, Walter J Urba, Heather L McArthur
A phase Ib trial of pembrolizumab plus paclitaxel or flat-dose capecitabine in 1st/2nd line metastatic triple-negative breast cancer. NPJ breast cancer 9 (1) (2023)
Jacob G Comeaux, Julie O Culver, John E Lee, Danielle S Dondanville, Heather L McArthur, Emily A Quinn, Nicholas Gorman, Charité N Ricker, Ming Li, Caryn Lerman
Risk-reducing mastectomy decisions among women with mutations in high- and moderate- penetrance breast cancer susceptibility genes. Molecular genetics & genomic medicine 10 (10) (2022)
David B Page, Kathryn Beal, Stefanie N Linch, Kateri J Spinelli, Micaela Rodine, Darragh Halpenny, Shanu Modi, Sujata Patil, Robert J Young, Thomas Kaley, Taha Merghoub, David Redmond, Phillip Wong, Christopher A Barker, Adi Diab, Larry Norton, Heather L McArthur
Brain radiotherapy, tremelimumab-mediated CTLA-4-directed blockade +/- trastuzumab in patients with breast cancer brain metastases. NPJ breast cancer 8 (1) (2022)
Beverly Moy, R Bryan Rumble, Steven E Come, Nancy E Davidson, Andrea Gombos, Julie R Gralow, Gabriel N Hortobagyi, Douglas Yee, Ian E Smith, Mariana Chavez Mac Gregor, Rita Nanda, Heather L McArthur, Laura M Spring, Katherine E Reeder-Hayes, Kathryn J Ruddy, Paul S Unger, Shaveta Vinayak, William J Irvin, Avan Armaghani, Michael A Danso, Natalie R Dickson, Sophie S Turner, Cheryl L Perkins, Lisa Anne Carey
Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (35) (2021)